medigraphic.com
Instituto Nacional de Salud Pública

2008, Number 5

<< Back Next >>

salud publica mex 2008; 50 (5)

Infección por Virus de Papiloma Humano en hombres de Brasil, México y EUA.

Language: English
References: 31
Page: 408-418
PDF size: 214.27 Kb.


ABSTRACT

Objective. To assess Human Papillomavirus (HPV) type distribution among men ages 18 years and older recruited from three different countries utilizing a common protocol for sampling HPV detection, and to evaluate whether HPV detection differs by age and country. Material and Methods. The study protocol includes a pre-enrollment run-in visit, a baseline (enrollment) visit, and nine additional visits after enrollment scheduled six months apart. For this analysis, the first 1 160 men who completed both the run-in and baseline visit were included. To maximize sampling and prevent fraying of applicators, three different applicators were utilized to sample the external genitalia of participants among different anatomic sites. These samples were later combined to form a single sample for the detection of HPV using polymerase chain reaction (PCR) for amplification of a fragment of the HPV L1 gene. Results. Among 1 160 men from Brazil, Mexico, and with 12.0% oncogenic types only, 20.7% non-oncogenic types only, 17.8% both oncogenic and non-oncogenic, and 14.7% unclassified infections. Multiple HPV types were detected in 25.7% of study participants. HPV prevalence was higher in Brazil (72.3%) than in the U.S. (61.3%) and Mexico (61.9%). HPV 16 (6.5%), 51 (6.5%), and 59 (5.3%) were the most commonly detected oncogenic infections, and HPV 84 (7.7%), 62 (7.3%), and 6 (6.6%) were the most commonly detected non-oncogenic infections. Overall HPV prevalence was not associated with age. However, significant associations with age were observed when specific categories of oncogenic, non-oncogenic, and unclassified HPV infections were considered. Conclusions. Studies of HPV type distribution among a broad age range of men from multiple countries is needed to fill the information gap internationally with respect to our knowledge of HPV infection in men. the United States (U.S.), overall HPV prevalence was 65.2%;


REFERENCES

  1. Agarwal SS, Sehgal A, Sardana S, Kumar A, Luthra UK. Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer 1993;72:1666-1669.

  2. Buckley JD, Harris RW, Doll R, Vessey MP, Williams PT. Case-control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet 1981;2:1010-1015.

  3. Thomas DB, Ray RM, Pardthaisong T, Chutivangse S, Koetsawang S,Silpisornkosol S, et al. Prostitution, condom use, and invasive squamous cell cervical cancer in Thailand. Am J Epidemiol 1996;143:779-786.

  4. Zunzunegui MV, King MC, Coria CF, Charlet J. Male influences on cervical cancer risk. Am J Epidemiol 1986;123:302-307.

  5. Bosch FX, Castellsague X, Munoz N, De SDanjosé S, Ghaffari AM,González LC. Meijer CU, Shah KV, De Sanjosé S, et al. Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996;88:1060-1067.

  6. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 1996;346:1105-1112.

  7. Shah KV. Human papillomaviruses and anogenital cancers. N Engl J Med 1997;337:1386-1388.

  8. Giuliano AR, Salmon D. The Case for a Gender Neutral (Universal) HPV Vaccination Policy in the US. Cancer Epidemiol Biomarkers Prev. 2008;(4):805-808.

  9. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR.Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis 2006;194:1044-1057.

  10. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a metaanalysis. Br J Cancer 2003;89:101-105.

  11. Flores R, Abalos TA, Nielson CM, Abrahamsen M, Harris RB, Giuliano AR.Reliability of sample collection and laboratory testing for HPV Detection in Men. J Virol Methods 2008;149(1):136-143.

  12. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M,Papenfuss MR, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007;196:1146-1152.

  13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. Journal of Clinical Microbiology 2000;38:357-361.

  14. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. Journal of Clinical Microbiology 1998;36:3020-3027.

  15. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassa F, et al.Carcinogenicity of human papillomaviruses. Lancet Oncology 2005;6:204.

  16. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ,Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3’ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76(Pt 4):1057-1062.

  17. Holm S. A Simple Sequentially Rejective Bonferroni Test Procedure.Scandinavian Journal of Statistics 1979;6:65-70.

  18. Nielson CM, Flores R, Harris RB, Abrahamsen M, Papenfuss MR,Dunne EF, et al. Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev. 2007;16:1107-1114.

  19. Rombaldi RL, Serafini EP, Villa LL, Vanni AC, Barea F, Frassini R, et al. Infection with human papillomaviruses of sexual partners of women having cervical intraepithelial neoplasia. Braz J Med Biol Res. 2006;39:177-87.

  20. Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M,Ngelangel C, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002;86:705-711.

  21. Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi, S,Hernández-Avila M, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev 2005;14:1710-1716.

  22. Lazcano-Ponce E, Herrero R, Munoz N, Hernández-Avila M, Salmeron J, Leyva A, et al. High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 2001;28:277-280.

  23. Vaccarella S, Lazcano-Ponce E, Castro-Garduno JA, Valdez A, Díaz V,Schiavon R, et al. Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico. Int J Cancer 2006;119:1934-1939.

  24. Hernandez BY, Goodman MT, Wilkens LR, Thompson P, Zhu X, Wong W, et al. Comparison of physician- and self-collected genital specimens for detection of human papillomavirus in men. J Clin Microbiol 2006;44: 513-517.

  25. Weaver BA, Holmes KK, Kiviat N, Lee SK, Meyer C, Stern M, et al.Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004;189:677-685.

  26. Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Giuliano AR. Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis 2004;31:601-607.

  27. Bleeker MC, Hogewoning C, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, et al. Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005;41:612-620.

  28. Shin HR, Vaccarella S, Roh JW, Ju YH, Oh JK, Kong HJ, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004;190:468-476.

  29. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361-367.

  30. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003;138:453-459.

  31. Svare EI, Kjaer S, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ. Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002;78:215-218.




2020     |     www.medigraphic.com